IGHE and allergic disease: Our data showed that immunization with HEL and PGMC in the presence of NaSal through the skin did not induce an antigen-specific IgE-dependent anaphylactic reaction, suggesting the potential use of NaSal in the development of a vaccine with a low or no allergic reaction and for its use in immunotherapy.